Welcome to
Apath.com
Apath is a privately held
technology licensing company with a focus on hepatitis C
virus (HCV) and other human viral pathogens. Apath
applies state-of-the art molecular virology and viral
genetics in order to assist clients in the discovery and
development of novel therapeutic products for the
treatment of viral infections. Apath’s primary focus
is on RNA viruses. Most medically important viruses are
RNA viruses including hepatitis C virus, influenza
virus, respiratory syncytial virus (RSV), and
hemorrhagic fever viruses.
Apath's founder and key employees have a proven track
record and comprehensive expertise in virology and
molecular biology. Apath has key patents, proprietary
know-how, and license agreements related to hepatitis C
virus (HCV) and other important human viral pathogens.
In addition, Apath has a proprietary antiviral screening
platform.
